Recent research has focused on the role of calcium-activated potassium (K +) channels, particularly small-conductance calcium-activated K + (SK) channels, in the pathophysiology of AF. These ...
Qlaris Bio is seeing double when it comes to phase 2 wins for its eye drug, hitting the primary endpoints in trials that both spanned primary open angle glaucoma (POAG) and ocular hypertension (OHT).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback